ALPS Medical Breakthroughs ETF
SBIO
66 hedge funds and large institutions have $67.5M invested in ALPS Medical Breakthroughs ETF in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 23 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
10% more funds holding
Funds holding: 60 → 66 (+6)
1.99% more ownership
Funds ownership: 35.39% → 37.38% (+2%)
6% less capital invested
Capital invested by funds: $71.7M → $67.5M (-$4.16M)
61% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Matisse Capital
Portland,
Oregon
|
+$5.99M |
| 2 |
SFS
Strategic Financial Services
Utica,
New York
|
+$674K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$522K |
| 4 |
EWA
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
|
+$487K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$481K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.08M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$921K |
| 3 |
MML Investors Services
Springfield,
Massachusetts
|
-$644K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$586K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$304K |
SBIO Hedge Fund Activity: Q4 2021 in Review
66 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2021, worth a combined $67.5M — down 5.8% from $71.7M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new SBIO positions and 4 closed out — a net gain of 7 holders — while 9 added to existing stakes and 23 trimmed.
The largest buyer was Matisse Capital, adding an estimated $5.99M. The largest seller was Bank of America, cutting an estimated $1.08M.
- 66 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2021, up from 60 in Q3 2021.
- Funds reported $67.5M of ALPS Medical Breakthroughs ETF stock for Q4 2021, down 5.8% quarter-over-quarter.
- 11 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2021 and 4 closed out, a net change of +7 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q4 2021 was Matisse Capital, an estimated $5.99M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q4 2021 was Bank of America, an estimated $1.08M sold.
Based on aggregated 13F filings for Q4 2021.